<DOC>
	<DOC>NCT01221909</DOC>
	<brief_summary>Single dose tranexamic acid (TA) before dacryocystorhinostomy (DCR) operation: a prospective, double blind, placebo controlled study. The study hypothesis: TA in DCR might reduce the intraoperative and postoperative bleeding in DCR surgery, and might reduce the duration of the surgery.</brief_summary>
	<brief_title>Tranexamic Acid in Dacryocystorhinostomy</brief_title>
	<detailed_description />
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>obstruction of nasolacrimal pathway eligible for DCR surgery 18 years of age or older warfarin treatment renal insufficiency pregnancy mental retardation tendency to bleed thromboembolic disease thrombophilia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>bleeding</keyword>
	<keyword>dacryocystorhinostomy</keyword>
	<keyword>operative duration</keyword>
</DOC>